Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11407838 Erenumab compositions and uses thereof

Patent 11407838 was granted and assigned to Amgen on August, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jose Gregorio Ramirez0

Kenneth Lawson0

Noel Rieder0

Suminda Hapuarachchi0

Date of Patent

August 9, 2022

0

Patent Application Number

163722910

Date Filed

April 1, 2019

0

Patent Citations

US Patent 10259877 Methods for treating or preventing migraine headache

Patent Citations Received

US Patent 12122841 Human CGRP receptor binding proteins

0

US Patent 12134652 Human CGRP receptor binding proteins

0

Patent Primary Examiner

Kimberly Ballard

0

CPC Code

0

0

0

0

0

0

0

0

...

The present invention relates to compositions comprising erenumab and one or more erenumab variants, including isomerization variants, deamidation variants, acidic variants, and HMW species. Pharmaceutical formulations comprising the erenumab compositions and methods of using and characterizing the compositions are also described.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11407838 Erenumab compositions and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool